Working Hours

Mon - Sat 9:00 - 6:00
LIN + VE TAB 600MG
LIN + VE TAB 600MG

LIN + VE TAB 600MG

Price 354.0 INR/ Box

MOQ : 50 Boxes

LIN + VE TAB 600MG Specification

  • Ingredients
  • Brand Name: LIN+IV 600 mg Tablet Generic Name / Content: Linezolid Tablet I.P. 600 mg Company: Aurobindo Pharma Ltd LIN+IV 600 mg Tablet contains Linezolid, a synthetic oxazolidinone-class antibiotic used for the treatment of serious Gram-positive bacterial infections. It works by inhibiting bacterial protein synthesis, effectively stopping the growth and multiplication of susceptible bacteria. This oral formulation is suitable for patients requiring outpatient therapy or for hospital use when intravenous therapy is not needed. Indications Complicated skin and soft tissue infections Community-acquired pneumonia (CAP) Hospital-acquired pneumonia (HAP) Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) Vancomycin-resistant Enterococcus faecium (VRE) infections Key Features Oxazolidinone-class broad-spectrum antibiotic Effective against multidrug-resistant Gram-positive bacteria Oral tablet formulation for easy administration Rapid onset of action Manufactured by Aurobindo Pharma Ltd Dosage Form & Category Dosage Form: Tablet Category: Oral Antibiotic (Oxazolidinone Class) Strength: 600 mg Content: Linezolid I.P. Packaging & Storage Supplied in blister packs or bottles as per packaging Store in a cool, dry place below 25 C Protect from light and moisture Use under qualified medical supervision
  • Quantity
  • 50 Boxes
 

LIN + VE TAB 600MG Trade Information

  • Minimum Order Quantity
  • 50 Boxes
  • Payment Terms
  • Cash in Advance (CID)
  • Supply Ability
  • 5000 Boxes Per Month
  • Delivery Time
  • 7 Days
  • Main Domestic Market
  • All India
 

About LIN + VE TAB 600MG

Brand Name: LIN+IV 600 mg Tablet
Generic Name / Content: Linezolid Tablet I.P. 600 mg
Company: Aurobindo Pharma Ltd

LIN+IV 600 mg Tablet contains Linezolid, a synthetic oxazolidinone-class antibiotic used for the treatment of serious Gram-positive bacterial infections. It works by inhibiting bacterial protein synthesis, effectively stopping the growth and multiplication of susceptible bacteria.

This oral formulation is suitable for patients requiring outpatient therapy or for hospital use when intravenous therapy is not needed.

Indications

Complicated skin and soft tissue infections

Community-acquired pneumonia (CAP)

Hospital-acquired pneumonia (HAP)

Infections caused by methicillin-resistant Staphylococcus aureus (MRSA)

Vancomycin-resistant Enterococcus faecium (VRE) infections

Key Features

Oxazolidinone-class broad-spectrum antibiotic

Effective against multidrug-resistant Gram-positive bacteria

Oral tablet formulation for easy administration

Rapid onset of action

Manufactured by Aurobindo Pharma Ltd

Dosage Form & Category

Dosage Form: Tablet

Category: Oral Antibiotic (Oxazolidinone Class)

Strength: 600 mg

Content: Linezolid I.P.

Packaging & Storage

Supplied in blister packs or bottles as per packaging

Store in a cool, dry place below 25C

Protect from light and moisture

Use under qualified medical supervision




Powerful Protection Against Resistant Infections

LIN+IV 600 mg Tablet is specially formulated to target and treat severe infections caused by bacteria that are resistant to multiple drugs, such as MRSA and VRE. Its advanced mechanism inhibits bacterial protein synthesis, ensuring rapid and effective clearing of infections that may not respond to standard antibiotics.


Convenient Oral Therapy for Serious Illness

This oral tablet is an ideal option for patients who require strong antibiotic therapy outside of a hospital setting or when intravenous administration is unnecessary. The easy-to-administer tablets simplify treatment regimens without compromising on efficacy, ensuring consistent dosing and optimal patient compliance.


Guidance, Safety, and Storage

Manufactured under stringent conditions, LIN+IV 600 mg Tablet comes in secure packaging for safety and stability. It should be stored in a cool, dry place below 25C, shielded from light and moisture. Always use this medication as directed by qualified healthcare professionals for best outcomes.

FAQ's of LIN + VE TAB 600MG:


Q: How does LIN+IV 600 mg Tablet work to treat infections?

A: LIN+IV 600 mg Tablet contains Linezolid, which acts by blocking bacterial protein synthesis. This action stops the growth and multiplication of susceptible Gram-positive bacteria, making it highly effective against infections that do not respond to other antibiotics.

Q: What types of infections is LIN+IV 600 mg Tablet used for?

A: LIN+IV 600 mg Tablet is indicated for complicated skin and soft tissue infections, community-acquired pneumonia (CAP), hospital-acquired pneumonia (HAP), and infections caused by multidrug-resistant bacteria such as MRSA and VRE.

Q: When should LIN+IV 600 mg Tablet be administered?

A: LIN+IV 600 mg Tablet is typically used when a patient has a confirmed or suspected Gram-positive bacterial infection, particularly when resistance to standard antibiotics is evident, and where oral therapy is deemed appropriate by a healthcare provider.

Q: Where should LIN+IV 600 mg Tablet be stored to maintain its efficacy?

A: The tablet should be stored in a cool, dry place below 25C, protected from light and moisture, and kept in its original packaging to ensure stability and effectiveness.

Q: What is the recommended usage process for LIN+IV 600 mg Tablet?

A: LIN+IV 600 mg Tablet should be taken as prescribed by your physician, usually at regular intervals, and for the full course of treatment even if symptoms improve earlier. Do not miss doses and do not discontinue use without consulting your doctor.

Q: What are the primary benefits of using LIN+IV 600 mg Tablet?

A: LIN+IV 600 mg Tablet offers broad-spectrum activity against resistant Gram-positive bacteria, rapid onset of action, and the convenience of oral administration, making it suitable for outpatient or hospital care without intravenous therapy.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anaesthetics Injection Category

CASPOTAZ 70MG

CASPOTAZ 70MG

Price 4500.0 INR / Piece

Minimum Order Quantity : 50 Pieces

Ingredients : Brand Name: Caspotaz 70 mg Generic Name / Content: Caspofungin Acetate Injection 70 mg Company: Aurobindo Pharma Lt Caspotaz 70 mg Injection contains Caspofungin Acetate, an echinocandinclass antifungal agent used for the treatment of serious and invasive fungal infections. It works by inhibiting the synthesis of (1,3)Dglucan, an essential component of the fungal cell wall, resulting in fungal cell death. This sterile injectable formulation is intended for intravenous (IV) administration in hospital and clinical settings under the supervision of qualified healthcare professionals. Indications Invasive candidiasis Esophageal candidiasis Invasive aspergillosis (in patients intolerant or refractory to other antifungal therapies) Empirical therapy in febrile neutropenic patients suspected of fungal infection Key Features Echinocandin class antifungal Broad activity against Candida and Aspergillus species Effective in severe systemic fungal infections Sterile IV formulation for hospital use Manufactured by Aurobindo Pharma Ltd Dosage Form & Category Dosage Form: Injection (Vial) Category: Injectable / Parenteral Antifungal Strength: 70 mg per vial Content: Caspofungin Acetate Packaging & Storage Supplied in sterile vial packaging Store as per label instructions (usually 2 8 C) Protect from light Use under medical supervision only

Quantity : 50 Pieces

Drug Type : Injection

Storage Instructions : Cool & Dry Place

CASPOTAZ 50

CASPOTAZ 50

Price 3584.0 INR / Piece

Minimum Order Quantity : 50 Pieces

Ingredients : Brand Name: Caspotaz 50 mg Generic Name / Content: Caspofungin Acetate Injection 50 mg Company: Aurobindo Pharma Ltd Caspotaz 50 mg Injection contains Caspofungin Acetate, an echinocandin class antifungal agent used for the treatment of serious fungal infections. It works by inhibiting the synthesis of (1,3)Dglucan, an essential component of the fungal cell wall, leading to fungal cell death. This sterile injectable formulation is intended for intravenous (IV) administration in hospital and clinical settings under medical supervision. Indications Invasive candidiasis Esophageal candidiasis Invasive aspergillosis (in patients refractory to or intolerant of other therapies) Empirical therapy for suspected fungal infections in febrile neutropenic patients Key Features Echinocandin class antifungal Effective against Candida and Aspergillus species Suitable for severe systemic fungal infections Sterile IV formulation Manufactured by Aurobindo Pharma Ltd Dosage Form & Category Dosage Form: Injection (Vial) Category: Injectable / Parenteral Antifungal Strength: 50 mg per vial Content: Caspofungin Acetate Packaging & Storage Supplied in sterile vial packaging Store as per label instructions (usually refrigerated, 2 8 C) Protect from light Use under qualified medical supervision

Quantity : 50 Pieces

Drug Type : Injection

Storage Instructions : Dry And Cool Place

LORTINIL TZ 1.125GM

LORTINIL TZ 1.125GM

Price 88.0 INR / Piece

Minimum Order Quantity : 50 Pieces

Ingredients : LORTINIL TZ Injection Ceftazidime & Tazobactam Brand Name: LORTINIL TZ Composition: Ceftazidime & Tazobactam Injection Manufacturer/Marketer: Aurobindo Pharma Ltd Veritaz Division Dosage Form: Dry Powder for Injection Packaging Type: Vial Route of Administration: Intravenous (IV) / Intramuscular (IM) Prescription Required: Yes Product Description: LORTINIL TZ Injection is a broadspectrum antibiotic combination containing Ceftazidime and Tazobactam. Ceftazidime is a thirdgeneration cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, while Tazobactam is a betalactamase inhibitor that enhances the effectiveness of Ceftazidime against resistant bacterial strains. It is widely used in hospitals and clinical settings for the treatment of moderate to severe bacterial infections. Indications: Respiratory tract infections Urinary tract infections Intraabdominal infections Skin and soft tissue infections Bone and joint infections Septicemia Key Features: Broadspectrum antibacterial coverage Effective against betalactamase producing organisms Suitable for critical care and hospital use Manufactured by a reputed pharmaceutical company Storage: Store in a cool, dry place below 25 C. Protect from light and moisture. Note: To be administered under the supervision of a qualified healthcare professional only.

Quantity : 50 Pieces

Drug Type : Injection

Storage Instructions : Cool & Dry Place

ROPIN 0.20% 50ML

ROPIN 0.20% 50ML

Price 306.5 INR / Piece

Minimum Order Quantity : 50 Pieces

Ingredients : ROPIN 0.20% 50ML Ropivacaine Hydrochloride Injection I.P. Brand: ROPIN Injection Content: Ropivacaine Hydrochloride I.P. 0.2% w/v (2 mg / ml) Company / Manufacturer: Neon Laboratories Ltd Pack: 50 ml Vial Category: Local Anesthetic / AmideType Regional AnestheticProduct Description ROPIN 0.20% 50ml Vial contains Ropivacaine Hydrochloride, a longacting amidetype local anesthetic solution formulated for parenteral administration. The 0.2% concentration is specifically designed to provide effective sensory nerve blockade while minimizing motor block, making it ideal for continuous pain relief. It is widely used in postoperative wards, intensive care units, and delivery rooms to provide stable, longlasting regional pain control during surgical recovery or childbirth with enhanced systemic safety margins.Key Uses Production of continuous epidural infusion analgesia for labor pain management during childbirth Postoperative pain management following major orthopedic, abdominal, or thoracic surgeries Continuous peripheral nerve blocks and infiltration anesthesia for local pain control Longterm acute pain management in intensive care settings How It Works Ropivacaine works by blocking the generation and conduction of nerve impulses. It diffuses into the nerve sheath and binds selectively to the intracellular sodium channels of nerve fibers. This action prevents the influx of sodium ions through the cell membrane, stopping the electrical depolarization of the nerve cell. By blocking these pathways, the drug temporarily prevents pain signals from traveling from the affected site up the spinal cord to the brain.Directions for Use Administer via epidural infusion, peripheral nerve block, or local tissue infiltration routes Visually check the solution inside the vial for any particles, leaks, or cloudiness before extraction Extract using clean, sterile syringes directly through the rubber stopper core Must be calculated, handled, and administered exclusively by a registered anesthesiologist or clinician Key Features Optimized concentration that provides reliable pain relief with minimal loss of skeletal muscle control Extended therapeutic window that delivers prolonged postsurgical and labor analgesia High volume 50 ml vial format designed to support continuous infusion pumps or repeated dosing protocols Fabricated under international sterile manufacturing standards by Neon Laboratories Ltd Possible Side Effects Hypotension or sudden temporary drop in systemic blood pressure Nausea, vomiting, or mild dizziness Important Safety Notes Storage Temperature: Store below 30 C in a cool, dry place. Protect from direct light lines and do not freeze. For local and regional blocks only; strictly contraindicated for intravenous regional anesthesia methods Avoid application directly into highly inflamed or infected tissue surfaces Schedule H Prescription Drug: Restricted for institutional supply to verified buyers with drug wholesale licenses

Quantity : 50 Unit

Drug Type : Injection



Back to top